HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 288/6/G1208    most recent 00505.2004v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (8) Citing Articles via Google Scholar Google Scholar Articles by Abitbol, M. Articles by Montagutelli, X. Search for Related Content PubMed PubMed Citation Articles by Abitbol, M. Articles by Montagutelli, X.

LIVER AND BILIARY TRACT

A mouse model provides evidence that genetic background modulates anemia and liver injury in erythropoietic protoporphyria

¹Unité de Génétique des Mammifères and URA 2579 CNRS, Institut Pasteur, Paris; ²UMR 955 INRA-ENVA de Génétique Moléculaire et Cellulaire and UP d'Histologie et d'Anatomie Pathologique, Ecole Nationale Vétérinaire d'Alfort, Maisons-Alfort; ³Centre Francais des Porphyries, INSERM U 656, Faculté X. Bichat, Hopital Louis Mourier, Colombes; and ⁴INSERM U 492-Université Paris XII, Faculté de Médecine, Créteil, France

Submitted 11 November 2004 ; accepted in final form 18 January 2005

Erythropoietic protoporphyria is an inherited disorder of heme biosynthesis caused by partial ferrochelatase deficiency, resulting in protoporphyrin (PP) overproduction by erythrocytes. In humans, it is responsible for painful skin photosensitivity and, occasionally, liver failure due to accumulation of PP in the liver. The ferrochelatase deficiency mouse mutation is the best animal model available for human erythropoietic protoporphyria. The original description, based on mice with a BALB/cByJCrl genetic background, reported a disease resembling the severe form of the human disease, with anemia, jaundice, and liver failure. Using congenic strains, we investigated the effect of genetic background on the severity of the phenotype. Compared with BALB/cByJCrl, C57BL/6JCrl mice developed moderate but increasing anemia and intense liver accumulation of PP with severe hepatocyte damage and loss. Bile excretory function was not affected, and bilirubin remained low. Despite the highest PP concentration in erythrocytes, anemia was mild and there were few PP deposits in the liver in SJL/JOrlCrl homozygotes. Discriminant analysis using six hematologic and biochemical parameters showed that homozygotes of the three genetic backgrounds could be clustered in three well-separated groups. These three congenic strains provide strong evidence for independent genetic control of bone marrow contribution of PP overproduction to development of liver disease and biliary PP excretion. They provide a tool to investigate the physiological mechanisms involved in these phenotypic differences and to identify modifying genes.

protoporphyrin; bilirubin; chronic hepatitis; ferrochelatase; congenic strains

This article has been cited by other articles:

				A V Anstey and R J Hift Liver disease in erythropoietic protoporphyria: insights and implications for management Postgrad. Med. J., December 1, 2007; 83(986): 739 - 748. [Full Text] [PDF]

				S. A. Holme, M. Worwood, A. V. Anstey, G. H. Elder, and M. N. Badminton Erythropoiesis and iron metabolism in dominant erythropoietic protoporphyria Blood, December 1, 2007; 110(12): 4108 - 4110. [Abstract] [Full Text] [PDF]

				C. Herrero, J. To-Figueras, C. Badenas, M. Mendez, P. Serrano, R. Enriquez-Salamanca, and M. Lecha Clinical, Biochemical, and Genetic Study of 11 Patients With Erythropoietic Protoporphyria Including One With Homozygous Disease Arch Dermatol, September 1, 2007; 143(9): 1125 - 1129. [Abstract] [Full Text] [PDF]

				A V Anstey and R J Hift Liver disease in erythropoietic protoporphyria: insights and implications for management Gut, July 1, 2007; 56(7): 1009 - 1018. [Full Text] [PDF]

				S. Lyoumi, M. Abitbol, V. Andrieu, D. Henin, E. Robert, C. Schmitt, L. Gouya, H. de Verneuil, J.-C. Deybach, X. Montagutelli, et al. Increased plasma transferrin, altered body iron distribution, and microcytic hypochromic anemia in ferrochelatase-deficient mice Blood, January 15, 2007; 109(2): 811 - 818. [Abstract] [Full Text] [PDF]